Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-06-02

Clinical Trial Update: Non-inferiority Trial of Two Snake Antivenoms in CAR (PAVES) [NA]

View source ↗

Summary

A non-inferiority trial of two snake antivenoms for snakebite envenomation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Epicentre | Conditions: Snake Bites | NA | Status: WITHDRAWN